Organization · Venture Capital
Humboldt Fund
Humboldt Fund is a venture capital fund based in New York, focusing on early-stage investments in synthetic biology and related sectors. The fund aims to support innovative companies that address significant global challenges through engineering and life sciences.
Overview
What Humboldt Fund does
What Humboldt Fund is
Humboldt Fund is a venture capital fund based in New York, focusing on early-stage investments in synthetic biology and related sectors. The fund aims to support innovative companies that address significant global challenges through engineering and life sciences.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- March 26, 2026
Official channels
Find Humboldt Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
Humboldt Fund as a funder
Investment thesis
Humboldt Fund focuses on investing in early-stage companies that leverage synthetic biology to create biology-based alternatives to industrial inputs, addressing significant global challenges while generating economic value.
Focus narrative
Humboldt Fund invests in early-stage companies, particularly in the synthetic biology sector, that are developing revolutionary technologies to solve significant challenges. The organization targets a variety of sectors where engineering intersects with life sciences, aiming to create substantial economic value through its investments.
Value beyond capital
Humboldt Fund provides deep scientific credibility and a strong network, particularly in Latin America and Europe, which distinguishes it from other US-focused funds. The team’s expertise in synthetic biology and their commitment to addressing global challenges adds significant value to their portfolio companies.
Terms and economics
- Typical check
- $500,000–$2,000,000
- Sweet spot
- $1,500,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Europe · Global · Latam · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 50
- Recorded notable exits
- NotCo and Metagenomi
Portfolio context
Humboldt Fund's portfolio includes over 50 companies, featuring notable names such as NotCo (a unicorn in plant-based food), Metagenomi (gene editing), Finch Therapeutics (microbiome therapeutics), and Mycoworks (mycelium materials). Other significant companies include Meatable (cultivated meat), Mission Barns (cultivated fat), and Geltor (fermentation-based proteins).
Common questions
What to know about Humboldt Fund
Upseed classifies Humboldt Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.